ROCKLAND, Mass.--(BUSINESS WIRE)--Sept. 13, 2006--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization, announced today that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at A.G. Edwards' Emerging Growth Conference 2006 on Wednesday, September 20, 2006 at 1:15 PM Eastern Time. The conference is being held at The New York Palace Hotel.
